Craig-Hallum downgraded Meridian Biosciences (NASDAQ: VIVO) from Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

Meridian Bioscience (VIVO) Reports In-Line Q4 EPSNovember 10, 2016 7:48 AM Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2017 Cash Dividend Rate, and Reaffirms Fiscal 2017 GuidanceNovember 10, 2016 7:45 AM